EUVIMEDEUVIMED entdecken
Crossref

Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-β pathology and cognitive impairment

Tianqi Yang, Dianjun Zhang, Haiwei Huang, Fangyue Liu, Juanli Wu, Xiaolin Ma, Shuangshuang Liu, Man Huang, Yu-Dong Zhou, Yi Shen iD

Brain · 08.01.2026 · 149 (1) · 134-149

DOI: 10.1093/brain/awaf186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 16.05.2025. Verfasst von Tianqi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Intensive Care Unit of the Second Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University Schoo…. Hauptthemen laut MEDLINE: Receptor, Metabotropic Glutamate 5, Astrocytes, Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Ministry of Science and Technology, NSFC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astrocytic dysfunction is a crucial factor in the pathogenesis of Alzheimer's disease. Metabotropic glutamate receptor 5 (mGluR5) is expressed ubiquitously in the brain and is a key molecule in regulating synaptic transmission and plasticity. It has been shown that mGluR5 is elevated in astrocytes in Alzheimer's disease. However, it remains elusive how astrocytic mGluR5 contributes to the pathogenesis of Alzheimer's disease. Here, we first quantified a high expression level of astrocytic mGluR5 in the hippocampus of Alzheimer's disease brains and demonstrated that the expression of astrocytic mGluR5 was positively correlated with Alzheimer's disease progression in both humans and mice. Upregulating astrocytic mGluR5 in the CA1 region at an early stage accelerated, whereas downregulating these receptors rescued, amyloid-β (Aβ) pathology and cognitive impairment in Alzheimer's disease mice. Moreover, the activation of mGluR5 led to calcium hyperactivity in astrocytes, causing Aβ pathology progression due to dysregulated Aβ uptake and degradation in astrocytes. Importantly, attenuating astrocytic calcium hyperactivity in the hippocampal CA1 region in the prodromal phase ameliorated Aβ pathology and cognitive defects in Alzheimer's disease mice. Our findings thus reveal a fundamental contribution of astrocytic mGluR5 in presymptomatic Alzheimer's disease that may serve as a potential diagnostic and therapeutic target for early Alzheimer's disease pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Metabotropic Glutamate 5AstrocytesAmyloid beta-PeptidesAlzheimer DiseaseCognitive DysfunctionCalciumAnimalsMiceHumansMaleMice, TransgenicFemaleMice, Inbred C57BLHippocampusCA1 Region, HippocampalDisease Models, AnimalAged

Stichwörter der Autor:innen

Alzheimer's diseaseastrocytic calcium hyperactivityastrocytic mGluR5soluble Aβ oligomerssynapse function

Substanzen

Receptor, Metabotropic Glutamate 5Amyloid beta-PeptidesCalciumGrm5 protein, mouseGRM5 protein, human

Autor:innen und Institutionen

  • Department of General Intensive Care Unit of the Second Affiliated Hospital and School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Nanhu Brain-Computer Interface Institute, MOE Frontier Science Center for Brain Research and Brain-Machine Integration, Zhejiang University, Hangzhou 311100, China.
  • NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain-Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou 310058, China.
  • National Health and Disease Human Brain Tissue Resource Center, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Core Facilities, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Department of General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China.

ORCID-Profile: Yi Shen

Förderung

  • Ministry of Science and Technology
  • NSFC

Zitieren

APA

Yang, T., Zhang, D., Huang, H., Liu, F., Wu, J., Ma, X., Liu, S., Huang, M., Zhou, Y. D., & Shen, Y. (2026). Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-β pathology and cognitive impairment. Brain, 149(1), 134-149. https://doi.org/10.1093/brain/awaf186

Vancouver

Yang T, Zhang D, Huang H, Liu F, Wu J, Ma X, et al. Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-β pathology and cognitive impairment. Brain. 2026;149(1):134-149. doi:10.1093/brain/awaf186

BibTeX
@article{Yang2026,
  author = {Yang, Tianqi and Zhang, Dianjun and Huang, Haiwei and Liu, Fangyue and Wu, Juanli and Ma, Xiaolin and Liu, Shuangshuang and Huang, Man and Zhou, Yu-Dong and Shen, Yi},
  title = {Astrocytic mGluR5-dependent calcium hyperactivity promotes amyloid-β pathology and cognitive impairment},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {1},
  pages = {134--149},
  doi = {10.1093/brain/awaf186}
}
Kostenlos starten →